Aktie AEMD AETHLON MEDICAL, INC.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren
Inaktiver Wert

Andere Sprachen Aethlon Medical, Inc. OTC Bulletin Board

Aktien

AEMD

US00808Y1091

AEMD

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Top Midday Decliners
Aethlon Medical Announces Pricing of $4.7 Million Public Offering
Aethlon Medical Reports Positive Results from an In Vitro Binding Study of Its Hemopurifier in Removing Extracellular Vesicles from Cancer Patient Plasma
Wall Street Set to Open Higher Monday as Investors Look Toward Key Inflation Figures
Investors Eye Key Inflation Data in Days Ahead as US Futures Trend Modestly Higher Monday
Aethlon Medical Reports Positive Results From an In Vitro Binding Study of Its Hemopurifier® in Removing Extracellular Vesicles From Cancer Patient Plasma
Aethlon Medical, Inc. Reports Positive Results from an In Vitro Binding Study of Its Hemopurifier in Removing Extracellular Vesicles from Cancer Patient Plasma
Aethlon Medical : Corporate Overview – May 2024
Aethlon Medical : Corporate Presentation April 2024
Aethlon Medical Enters Into Materials Transfer Agreement for Santersus AG's NucleoCapture and HemoNucleoCapture Devices
Aethlon Medical, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
Aethlon Medical Announces Fiscal Third Quarter Financial Results and Provides Corporate Update
Aethlon Medical to Release Fiscal Third Quarter Financial Results and Host Conference Call on February 14, 2024
Aethlon Medical Announces Fiscal Second Quarter Financial Results and Provides Corporate Update
Aethlon Medical, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
Aethlon Medical Announces Appointment of James B. Frakes, M.B.A. as Interim Chief Executive Officer and Guy Cipriani, M.B.A. as Chief Operating Officer
Aethlon Medical, Inc Announces Executive Changes
Aethlon Medical, Inc. Announces Appointment Ofguy Ciprian as Chief Operating Officer
Aethlon Medical to Release Second Quarter Financial Results and Host Conference Call on November 14, 2023
Aethlon Medical, Inc. Receives Clearance from Drug Controller General of India for Potential Phase 1 Trial of its Hemopurifier(R) in Oncology
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A3EW0P Aktie
  4. AEMD Aktie
  5. Nachrichten Aethlon Medical, Inc.
  6. Andere Sprachen